At 10.2% CAGR, Middle East & Africa Medical Writing Market is Speculated to be WWorth US$ 292.74 Million by 2031 says Business Market Insights

According to Business Market Insights’ research, the Middle East & Africa medical writing market was valued at US$ 134.43 million in 2023 and is expected to reach US$ 292.74 million by 2031, registering a CAGR of 10.2% from 2023 to 2031. Growing importance of medical writing to obtain approval from regulatory authorities and increasing demand for regulatory and clinical trial documentation are among the critical factors attributed to drive the Middle East & Africa medical writing market.

Regulatory authorities require detailed information on methodologies followed during all phases of product development to approve products in the biopharmaceutical and pharmaceutical industries. Further, insurance providers require all necessary information about drugs to determine reimbursement policies. Therefore, it becomes a challenging task for biopharmaceutical and pharmaceutical companies to keep up with the industry norms.

The medical writers involved in medical writing are exposed to different tasks that provide valuable insights into protocol design. The data generated from clinical trials reflects all the required information about product labeling, providing summaries for statistical and highly complex data and also offering suggestions for process improvements in understandable language devoid of jargon. The information contained in medical writings is clarified before disclosing the trial results to the public. Medical writers are capable of quickly processing and analyzing the information as per the required rules and regulations by implementing solutions to accelerate the document developing process, thereby allowing to speed up the entire process of drug development. Owing to these benefits, medical writing is gaining significant importance in seeking regulatory approvals without hassles.

On the contrary, insufficient skilled medical writers hamper the growth of Middle East & Africa medical writing market.

Based on type, the Middle East & Africa medical writing market is segmented into clinical writing, regulatory writing, scientific writing, and others. The clinical writing segment held 44.3% market share in 2023, amassing US$ 59.56 million. It is projected to garner US$ 134.46 million by 2031 to register 10.7% CAGR during 2023–2031.

By application, the Middle East & Africa medical writing market is segmented into medical journalism, medical education, and medico marketing. The medical journalism segment held 60.6% share of Middle East & Africa medical writing market in 2023, amassing US$ 81.42 million. It is projected to garner US$ 179.93 million by 2031 to expand at 10.4% CAGR from 2023 to 2031.

Based on end user, the Middle East & Africa medical writing market is bifurcated into pharmaceutical & biotechnology companies and contract research organizations. The pharmaceutical & biotechnology companies segment held 70.6% market share in 2023, amassing US$ 94.86 million. It is projected to garner US$ 214.73 million by 2031 to register 10.8% CAGR during 2023–2031.

Based on country, the Middle East & Africa medical writing market is categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that South Africa captured 41.5% share of Middle East & Africa medical writing market in 2023. It was assessed at US$ 55.77 million in 2023 and is likely to hit US$ 126.90 million by 2031, registering a CAGR of 10.8% during 2023 to 2031.

Key players operating in the medical writing market are Cactus Communications, Parexel International Corp, Certara Inc, Freyr LLC, Quanticate International Ltd, SIRO Clinpharm Pvt Ltd, ProPharma Group, Caidya, Wipro Ltd, SGS SA, Laboratory Corp of America Holdings, TUNECT, Indegene Ltd, Evidera, Syner-G BioPharma Group, EMTEX BV, BioAgile Therapeutics Private Limited, Tata Consultancy Services Ltd, InClin, and TransPerfect Life Sciences, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com